Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,006,344

« Back to Dashboard

Summary for Patent: 5,006,344

Title: Fosinopril tablet formulations
Abstract:Shelf stable tablets containing fosinopril sodium are prepared by employing either sodium stearyl fumarate or hydrogenated vegetable oil as the lubricant. The tablets can contain conventional excipients such as fillers, binders, and disintegrants as well as an optional diuretic.
Inventor(s): Jerzewski; Robert L. (East Millstone, NJ), Wong; Thomas M. (North Brunswick, NJ), Gryziewicz; Lewis J. (North Brunswick, NJ), Jain; Nemichand B. (Monmouth Junction, NJ), Thakur; Ajit B. (East Brunswick, NJ)
Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ)
Application Number:07/543,639
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;

No matches for this query

International Patent Family for Patent: 5,006,344

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria100321► Subscribe
Canada2019324► Subscribe
German Democratic Republic299154► Subscribe
Germany69006125► Subscribe
Denmark0408273► Subscribe
European Patent Office0408273► Subscribe
Spain2062376► Subscribe
Japan2965633► Subscribe
JapanH0348623► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus